Introduction
============

As the leading cause of death in Korea \[[@b1-crt-2020-203]\], cancer has been a major public health concern in the country since 1983. In 2016, over 220,000 patients were newly diagnosed with cancer in Korea, and one-fourth of deaths were due to cancer \[[@b2-crt-2020-203]\]. Although the cancer registration system in Korea is highly efficient and can provide nationwide cancer statistics within a relatively short period, a lag time of at least 2 years is required to collect and analyze data for a specific year. For planning and implementing comprehensive cancer-control programs, it is important to assess the number of new cases and deaths that are expected to occur during the current year. In this study, we report the projected cancer incidence and mortality for the year 2020 based on data from the 1990s to 2018.

Materials and Methods
=====================

The Korean Ministry of Health and Welfare initiated a nationwide, hospital-based cancer registry, known as the Korea Central Cancer Registry (KCCR), in 1980. The history, objectives, and activities of the KCCR have been documented in detail elsewhere \[[@b3-crt-2020-203]\]. Cancer incidence data from 1999 to 2017 were obtained from the Korea National Cancer Incidence Database (KNCI DB). Cancer cases were classified according to the International Classification of Diseases for Oncology, 3rd edition \[[@b4-crt-2020-203]\] and converted according to the International Classification of Diseases, 10th edition (ICD-10) \[[@b5-crt-2020-203]\]. Mortality data from 1993 to 2018 were acquired from Statistics Korea \[[@b1-crt-2020-203]\]. The cause of death was coded and classified according to the ICD-10 code \[[@b5-crt-2020-203]\].

The cancer sites included in this study were (1) all cancers sites combined and (2) the 24 most common cancer sites as follows: lips, oral cavity, and pharynx (C00-C14); esophagus (C15); stomach (C16); colon and rectum (C18-C20); liver (C22); gallbladder, etc. (C23-C24); pancreas (C25); larynx (C32); lung (C33-C34); breast (C50); cervix uteri (C53); corpus uteri (C54); ovary (C56); prostate (C61); testis (C62); kidney (C64); bladder (C67); brain and central nervous system (C70-C72); thyroid (C73); Hodgkin lymphoma (C81); non-Hodgkin lymphoma (C82-C86, C96); multiple myeloma (C90); leukemia (C91-C95); and "other and ill defined (remainder of C00-C96)" sites.

Population data from 1993 to 2020 were obtained from the resident registration population data, reported by Statistics Korea. Data on the mid-year population, as of July 1 of the respective year, were analyzed for the denominator. However, we used population data as of December 31, 2019 for the year 2020, because mid-2020 resident registration population data were not yet available at the time of the analysis.

Linear regression models \[[@b6-crt-2020-203]\] were used to assess time trends and create projections. We first performed a *Joinpoint* regression analysis on the data available to detect the year when significant changes occurred in cancer trends according to sex and cancer site. A *Joinpoint* regression describes changes in data trends by connecting several different line segments on a log scale at "joinpoints." This analysis was performed using the *Joinpoint* software (ver. 4.7.0.0, <http://surveillance.cancer.gov/joinpoint>) from the Surveillance Research Program of the US National Cancer Institute \[[@b7-crt-2020-203]\]. For the analysis, we arranged to have at least four data points between consecutive joinpoints. Secondly, to predict age-specific cancer rates, a linear regression model was fitted to age-specific rates by 5-year age groups against the observed years, based on the observed cancer incidence data of the latest trends, with the exception of the incidence of thyroid cancer. We used average age-specific rates from recent three consecutive years (2015-2017), taking into consideration the recent trends in the incidence rate of thyroid cancer.

Finally, we multiplied the projected age-specific rates by the age-specific population to get the projected number of cancer cases and deaths for the year 2020.

We summarized the results using crude rates (CRs) and age-standardized rates (ASRs) of cancer incidence and mortality. ASRs were standardized using the world standard population \[[@b8-crt-2020-203]\] and are expressed per 100,000 persons.

Results
=======

1. Incidence
------------

In total, 243,263 new cancer cases are expected to occur in 2020 ([Table 1](#t1-crt-2020-203){ref-type="table"}, [Fig. 1](#f1-crt-2020-203){ref-type="fig"}); more men (n=126,098) than women (n=117,165) are expected to be affected.

The projected CRs per 100,000 for all of the sites combined in 2020 are 487.5 and 450.9 in men and women, respectively ([Table 2](#t2-crt-2020-203){ref-type="table"}). The projected ASRs per 100,000 for all of the sites combined are 268.7 and 250.9 in men and women, respectively. In men, the five leading primary sites of cancer are expected to be the lung (CR, 78.6; ASR, 39.9), stomach (CR, 69.2; ASR, 37.2), colon and rectum (CR, 57.2; ASR, 30.5), prostate (CR, 56.3; ASR, 28.7), and liver (CR, 42.5; ASR, 22.9), accounting for 62.3% of all new cancer cases in 2020 ([Fig. 1A](#f1-crt-2020-203){ref-type="fig"}). In women, the five leading primary sites are expected to be the breast (CR, 98.0; ASR, 61.0), thyroid (CR, 80.3; ASR, 57.5), colon and rectum (CR, 42.7; ASR, 18.3), stomach (CR, 35.1; ASR, 16.5), and lung (CR, 34.5; ASR, 15.2), accounting for 64.4% of all new cancer cases in 2020 ([Fig. 1B](#f1-crt-2020-203){ref-type="fig"}).

The five most common cancer sites expected in 2020, according to sex and age groups, are shown in [Table 3](#t3-crt-2020-203){ref-type="table"}. Leukemia and thyroid cancer are expected to be the most common forms of cancer in both sexes for the 0-14 and 15-34 age groups, respectively. Stomach cancer is predicted to be the most prevalent cancer in men aged 35-64 years, while lung cancer is expected to be more frequent in men aged 65 years and above. Breast cancer is predicted to be the most common cancer in women aged 35-64 years, whereas colorectal cancer is expected to be the most prevalent in women aged 65 years and above. These projections indicate that the incidences of stomach, lung, liver, colorectal, and prostate cancers will increase gradually with age in men ([Fig. 2A](#f2-crt-2020-203){ref-type="fig"}). In women, the age-specific incidence rates for stomach, colorectal, liver, lung, and cervical cancers denote an increasing trend with age; however, the incidences of breast and thyroid cancers in women are expected to level off after the age of 40 years ([Fig. 2B](#f2-crt-2020-203){ref-type="fig"}).

2. Mortality
------------

It is estimated that 80,546 cancer deaths will occur in Korea during 2020 ([Table 1](#t1-crt-2020-203){ref-type="table"}, [Fig. 1](#f1-crt-2020-203){ref-type="fig"}). The projected CRs per 100,000 for all of the sites combined in 2020 for men and women are 190.5 and 120.3, respectively, whereas the projected ASRs per 100,000 for all of the sites combined for men and women are expected to be 98.0 and 48.2, respectively ([Table 4](#t4-crt-2020-203){ref-type="table"}). The predicted five leading cancer sites causing mortality in men are the lung (CR, 54.9; ASR, 27.2), liver (CR, 27.4; ASR, 14.6), colon and rectum (CR, 18.7; ASR, 9.6), stomach (CR, 15.7; ASR, 8.1), and pancreas (CR, 13.5; ASR, 7.0). During the same period, lung cancer (CR, 17.7; ASR, 6.3) is projected to be the leading cause of cancer death in women, followed by colon and rectal (CR, 15.1; ASR, 5.2), pancreatic (CR, 12.9; ASR, 4.8), liver (CR, 11.1; ASR, 4.0), and breast (CR, 10.6; ASR, 6.1) cancers.

The predicted age-specific mortality rates of the leading cause of cancer death in men and women in 2020 are shown in further detail in [Fig. 3](#f3-crt-2020-203){ref-type="fig"}. According to age, Korean men and women aged at least 60 years are expected to have the highest mortality rates due to lung cancer.

Conclusion
==========

A total of 243,263 new cancer cases and 80,546 cancer deaths are expected to occur in Korea during 2020. Lung cancer is predicted to be the most common type of cancer among men, followed by stomach, colorectal, prostate, and liver cancers. Lung, liver, colorectal, stomach, and pancreatic cancers are expected to be the most common causes of cancer deaths among men. In women, the five leading primary cancer sites are expected to be the breast, thyroid, colorectum, stomach, and lung, while lung, colorectal, pancreatic, liver, and breast cancers are projected to be the most common causes of cancer deaths.

Cancer is currently one of the foremost public health concerns in Korea. Although cancer incidence rates are anticipated to decrease slightly, the burden of most types of cancers will continue to grow with the increasing age of the population. The current projections of cancer incidence and mortality for 2020 represent an important resource for planning and evaluating cancer-control programs. As the estimates in this study are model-based, these results should be interpreted with caution.
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###### 

Estimated new cancer cases and deaths by sex during 2020 in Korea

  Site                                                         Estimated new cases   Estimated deaths                               
  ------------------------------------------------------------ --------------------- ------------------ --------- -------- -------- --------
  All sites                                                    243,263               126,098            117,165   80,546   49,284   31,262
  Lip, oral cavity, and pharynx                                3,915                 2,813              1,102     1,222    888      334
  Esophagus                                                    2,555                 2,317              238       1,278    1,140    138
  Stomach                                                      27,005                17,889             9,116     6,279    4,060    2,219
  Colon and rectum                                             25,881                14,789             11,092    8,758    4,847    3,911
  Liver^[a)](#tfn1-crt-2020-203){ref-type="table-fn"}^         14,670                10,994             3,676     9,961    7,090    2,871
  Gallbladder^[b)](#tfn2-crt-2020-203){ref-type="table-fn"}^   7,999                 4,244              3,755     5,235    2,809    2,426
  Pancreas                                                     8,331                 4,330              4,001     6,843    3,483    3,360
  Larynx                                                       1,085                 1,020              65        266      252      14
  Lung^[c)](#tfn3-crt-2020-203){ref-type="table-fn"}^          29,292                20,340             8,952     18,796   14,192   4,604
  Breast                                                       25,549                97                 25,452    2,766    18       2,748
  Cervix uteri                                                 3,148                 \-                 3,148     801      \-       801
  Corpus uteri                                                 3,261                 \-                 3,261     383      \-       383
  Ovary                                                        2,941                 \-                 2,941     1,309    \-       1,309
  Prostate                                                     14,561                14,561             \-        2,040    2,040    \-
  Testis                                                       308                   308                \-        18       18       \-
  Kidney                                                       5,923                 4,003              1,920     1,198    813      385
  Bladder                                                      4,832                 3,870              962       1,622    1,229    393
  Brain and CNS                                                2,122                 1,140              982       1,351    703      648
  Thyroid                                                      26,747                5,884              20,863    350      100      250
  Hodgkin lymphoma                                             342                   214                128       72       43       29
  Non-Hodgkin lymphoma                                         5,484                 3,161              2,323     2,145    1,230    915
  Multiple myeloma                                             1,963                 1,019              944       1,153    624      529
  Leukemia                                                     3,766                 2,167              1,599     2,041    1,187    854
  Other and ill defined                                        21,583                10,938             10,645    4,659    2,518    2,141

CNS, central nervous system.

Includes the liver and intrahepatic bile duct,

Includes the gallbladder and other/unspecified parts of the biliary tract,

Includes the lung and bronchus.

###### 

Estimated crude and age-standardized cancer incidences by sex during 2020 in Korea

  Site                                                         Crude incidence rate per 100,000   Age-standardized incidence rate per 100,000^[a)](#tfn4-crt-2020-203){ref-type="table-fn"}^                           
  ------------------------------------------------------------ ---------------------------------- -------------------------------------------------------------------------------------------- ------- ------- ------- -------
  All sites                                                    469.2                              487.5                                                                                        450.9   253.7   268.7   250.9
  Lip, oral cavity, and pharynx                                7.6                                10.9                                                                                         4.2     4.2     6.2     2.4
  Esophagus                                                    4.9                                9.0                                                                                          0.9     2.4     4.6     0.4
  Stomach                                                      52.1                               69.2                                                                                         35.1    27.1    37.2    16.5
  Colon and rectum                                             49.9                               57.2                                                                                         42.7    24.2    30.5    18.3
  Liver^[b)](#tfn5-crt-2020-203){ref-type="table-fn"}^         28.3                               42.5                                                                                         14.2    14.8    22.9    6.0
  Gallbladder^[c)](#tfn6-crt-2020-203){ref-type="table-fn"}^   15.4                               16.4                                                                                         14.5    6.7     8.3     5.4
  Pancreas                                                     16.1                               16.7                                                                                         15.4    7.3     8.8     6.2
  Larynx                                                       2.1                                3.9                                                                                          0.3     1.1     2.0     0.1
  Lung^[d)](#tfn7-crt-2020-203){ref-type="table-fn"}^          56.5                               78.6                                                                                         34.5    25.9    39.9    15.2
  Breast                                                       49.3                               0.4                                                                                          98.0    29.3    0.2     61.0
  Cervix uteri                                                 6.1                                \-                                                                                           12.1    3.5     \-      7.8
  Corpus uteri                                                 6.3                                \-                                                                                           12.6    3.6     \-      7.6
  Ovary                                                        5.7                                \-                                                                                           11.3    3.4     \-      7.0
  Prostate                                                     28.1                               56.3                                                                                         \-      12.4    28.7    \-
  Testis                                                       0.6                                1.2                                                                                          \-      0.6     1.2     \-
  Kidney                                                       11.4                               15.5                                                                                         7.4     6.2     9.1     4.0
  Bladder                                                      9.3                                15.0                                                                                         3.7     4.3     7.6     1.5
  Brain and CNS                                                4.1                                4.4                                                                                          3.8     3.0     3.3     2.7
  Thyroid                                                      51.6                               22.8                                                                                         80.3    36.4    16.0    57.5
  Hodgkin lymphoma                                             0.7                                0.8                                                                                          0.5     0.6     0.7     0.5
  Non-Hodgkin lymphoma                                         10.6                               12.2                                                                                         8.9     6.3     7.9     5.1
  Multiple myeloma                                             3.8                                3.9                                                                                          3.6     1.9     2.1     1.6
  Leukemia                                                     7.3                                8.4                                                                                          6.2     5.5     6.6     4.6
  Other and ill defined                                        41.6                               42.3                                                                                         41.0    22.1    24.8    19.5

CNS, central nervous system.

Age adjusted to the world standard population,

Includes the liver and intrahepatic bile duct,

Includes the gallbladder and other/unspecified parts of the biliary tract,

Includes the lung and bronchus.

###### 

Estimated cancer incidence by age group and sex during 2020 in Korea

  Rank        Age group (yr)                                                                                                                                          
  ----------- ------------------------------------------------------------ ---------------------------- ------------------------------------------------------------- --------------------------------------------------------------------
  **Men**                                                                                                                                                             
   1          Leukemia (4.9)                                               Thyroid (13.7)               Stomach (66.3)                                                Lung^[a)](#tfn8-crt-2020-203){ref-type="table-fn"}^ (428.6)
   2          Non-Hodgkin lymphoma (3.1)                                   Leukemia (3.8)               Colon and rectum (48.3)                                       Prostate (323.0)
   3          Brain and CNS (2.3)                                          Non-Hodgkin lymphoma (3.2)   Liver^[b)](#tfn9-crt-2020-203){ref-type="table-fn"}^ (44.2)   Stomach (276.7)
   4          Kidney (0.4)                                                 Testis (2.7)                 Lung^[a)](#tfn8-crt-2020-203){ref-type="table-fn"}^ (43.8)    Colon and rectum (248.7)
   5          Liver^[b)](#tfn9-crt-2020-203){ref-type="table-fn"}^ (0.3)   Colon and rectum (2.4)       Prostate (27.2)                                               Liver^[b)](#tfn9-crt-2020-203){ref-type="table-fn"}^ (156.8)
  **Women**                                                                                                                                                           
   1          Leukemia (4.0)                                               Thyroid (50.0)               Breast (164.1)                                                Colon and rectum (157.3)
   2          Brain and CNS (2.1)                                          Breast (12.0)                Thyroid (126.6)                                               Lung^[a)](#tfn8-crt-2020-203){ref-type="table-fn"}^ (124.3)
   3          Non-Hodgkin lymphoma (1.7)                                   Cervix uteri (5.5)           Stomach (31.7)                                                Stomach (112.3)
   4          Ovary (0.8)                                                  Ovary (3.4)                  Colon and rectum (30.9)                                       Breast (101.3)
   5          Thyroid (0.7)                                                Corpus uteri (2.5)           Lung^[a)](#tfn8-crt-2020-203){ref-type="table-fn"}^ (26.3)    Gallbladder^[c)](#tfn10-crt-2020-203){ref-type="table-fn"}^ (65.6)

CNS, central nervous system.

Includes the lung and bronchus,

Includes the liver and intrahepatic bile duct,

Includes the gallbladder and other/unspecified parts of the biliary tract.

###### 

Estimated crude and age-standardized cancer mortality rates by sex during 2020 in Korea

  Site                                                          Crude mortality rate per 100,000   Age-standardized mortality rate per 100,000^[a)](#tfn11-crt-2020-203){ref-type="table-fn"}^                         
  ------------------------------------------------------------- ---------------------------------- --------------------------------------------------------------------------------------------- ------- ------ ------ ------
  All sites                                                     155.3                              190.5                                                                                         120.3   69.4   98.0   48.2
  Lip, oral cavity, and pharynx                                 2.4                                3.4                                                                                           1.3     1.1    1.8    0.6
  Esophagus                                                     2.5                                4.4                                                                                           0.5     1.1    2.2    0.2
  Stomach                                                       12.1                               15.7                                                                                          8.5     5.3    8.1    3.1
  Colon and rectum                                              16.9                               18.7                                                                                          15.1    7.2    9.6    5.2
  Liver^[b)](#tfn12-crt-2020-203){ref-type="table-fn"}^         19.2                               27.4                                                                                          11.1    9.0    14.6   4.0
  Gallbladder^[c)](#tfn13-crt-2020-203){ref-type="table-fn"}^   10.1                               10.9                                                                                          9.3     4.1    5.4    3.0
  Pancreas                                                      13.2                               13.5                                                                                          12.9    5.8    7.0    4.8
  Larynx                                                        0.5                                1.0                                                                                           0.1     0.2    0.5    0.0
  Lung^[d)](#tfn14-crt-2020-203){ref-type="table-fn"}^          36.3                               54.9                                                                                          17.7    15.2   27.2   6.3
  Breast                                                        5.3                                0.1                                                                                           10.6    3.1    0.0    6.1
  Cervix uteri                                                  1.5                                \-                                                                                            3.1     0.9    \-     1.7
  Corpus uteri                                                  0.7                                \-                                                                                            1.5     0.4    \-     0.8
  Ovary                                                         2.5                                \-                                                                                            5.0     1.3    \-     2.5
  Prostate                                                      3.9                                7.9                                                                                           \-      1.4    3.7    \-
  Testis                                                        0.0                                0.1                                                                                           \-      0.0    0.1    \-
  Kidney                                                        2.3                                3.1                                                                                           1.5     1.1    1.7    0.6
  Bladder                                                       3.1                                4.8                                                                                           1.5     1.2    2.3    0.4
  Brain and CNS                                                 2.6                                2.7                                                                                           2.5     1.6    1.8    1.4
  Thyroid                                                       0.7                                0.4                                                                                           1.0     0.3    0.2    0.3
  Hodgkin lymphoma                                              0.1                                0.2                                                                                           0.1     0.1    0.1    0.1
  Non-Hodgkin lymphoma                                          4.1                                4.8                                                                                           3.5     1.9    2.5    1.4
  Multiple myeloma                                              2.2                                2.4                                                                                           2.0     1.0    1.2    0.8
  Leukemia                                                      3.9                                4.6                                                                                           3.3     2.1    2.7    1.6
  Other and ill defined                                         9.0                                9.7                                                                                           8.2     4.2    5.3    3.3

CNS, central nervous system.

Age adjusted to the world standard population,

Includes the liver and intrahepatic bile duct,

Includes the gallbladder and other/unspecified parts of the biliary tract,

Includes the lung and bronchus.
